New tetracyclic 6 azapyrazinoindolines as 5HT2C receptor agonists for obesity
申请人:Hebeisen Paul
公开号:US20060252759A1
公开(公告)日:2006-11-09
The present invention refers to chemical compounds of formula (I)
as well as pharmaceutically acceptable salts and esters thereof, wherein R
1
to R
5
have the significance given in claim 1. These compounds can be used for the preparation of medicaments.